Biotech stocks advanced in the penultimate week of the year, and the iShares NASDAQ Biotechnology Index (NASDAQ: IBB ) is on track to end the year with gains in excess of 25%. The previous week saw FD

31 Healthcare Stocks Moving In Friday's Pre-Market Session

12:00am, Friday, 27'th Dec 2019

Oncolytics Biotech Stock News

26 Biotechnology Stocks Moving In Wednesday's After-Market Session

20 Biotechnology Stocks Moving In Tuesday's After-Market Session

80 Biggest Movers From Yesterday

85 Biggest Movers From Yesterday

50 Biggest Movers From Yesterday

30 Stocks Moving In Monday's Mid-Day Session

Oncolytics Biotech shares are trading higher. Not seeing any company-specific news to justify the price action.

65 Biggest Movers From Yesterday

Oncolytics biotech shares are trading lower as a potential sell-off after the stock increased roughly 185% over the last 5 trading sessions.

Mid-Day Market Update: Neovasc Jumps After Submitting Approval Application For Neovasc Reducer; EyeGate Pharmaceuticals Shares Plummet

32 Stocks Moving In Monday's Mid-Day Session

Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus

31 Healthcare Stocks Moving In Friday's Pre-Market Session

Oncolytics Biotech shares are trading higher on more than triple average volume. Not currently seen any news to justify the price action.

Oncolytics Bio regains Nasdaq listing compliance

Top Fintech Company